Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-06 11:31:16 - browse：68312

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： PBMs are inflating the cost of generic drugs. They must be reined in

WSS

First over

Study: Spinal cord stimulation helps patients with paralysis walk again

Longer MASH drug regimen improved liver, Akero study finds

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

The public health thinking behind the CDC’s new Covid guidance

How to make over

hotspot

Wikipedia

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

As obesity drug market grows, telehealth companies court payers

Alkermes shareholders re

Kellogg’s is going to war over Mexico’s nutrition label rules

Trump demands the U.S. pay no more for drugs than other countries … again

Change Healthcare: What is it, why does its cyberattack matter?

Wildfire smoke exposes gaps in outdoor worker protections

Stem cell biologist probes earliest stages of human development

Walensky prepares to leave CDC — and Congress — behind

Roche's accidental data boosts hopes for anti

explore

Former Pear Therapeutics executives start new VC firm

Medicare drug price negotiation continues, as pharma counteroffers

PBMs are inflating the cost of generic drugs. They must be reined in

DeSantis wants to import drugs. Biden’s FDA blasted his plan

The public health thinking behind the CDC’s new Covid guidance

Kellogg’s is going to war over Mexico’s nutrition label rules

Wikipedia

focus

hotspot

entertainment